Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 5/20 | 0.61 |
| ▸ | NPC1 | O15118 | 4/20 | 0.61 |
| ▸ | TP53 | P04637 | 2/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | HTT | P42858 | 2/20 | 0.61 |
| ▸ | KDM1A | O60341 | 1/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.55 |
| ▸ | MEN1 | O00255 | 3/20 | 0.55 |
| ▸ | MAPT | P10636 | 3/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 2/20 | 0.53 |
| ▸ | MMP1 | P03956 | 2/20 | 0.52 |
| ▸ | MMP2 | P08253 | 2/20 | 0.52 |
| ▸ | MMP9 | P14780 | 2/20 | 0.52 |
| ▸ | METAP2 | P50579 | 1/20 | 0.52 |
| ▸ | TOP1 | P11387 | 1/20 | 0.48 |
| ▸ | TOP2A | P11388 | 1/20 | 0.48 |
| ▸ | TOP2B | Q02880 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29807803 | 1.00 | GAA (0.61) | GAANPC1TP53LMNAHTT | |
| Sulfuric Acid SCHEMBL11242328 | 0.92 | GAA (0.53) | GAANPC1TP53LMNAHTT | |
| SCHEMBL29840068 | 0.87 | GAA (0.67) | GAANPC1TP53LMNAHTT | |
| SCHEMBL3928666 | 0.87 | GAA (0.67) | GAANPC1TP53LMNAHTT | |
| SCHEMBL5084657 | 0.85 | NPC1 (0.55) | GAANPC1TP53LMNAHTT | |
| SCHEMBL5332499 | 0.85 | GAA (0.50) | GAANPC1TP53LMNAHTT | |
| SCHEMBL15259585 | 0.83 | KDM4E (0.57) | GAATP53LMNAHTTKDM4E | |
| SCHEMBL9400389 | 0.83 | NPC1 (0.66) | GAANPC1TP53LMNAHTT | |
| SCHEMBL29473469 | 0.83 | NPC1 (0.63) | GAANPC1TP53LMNAHTT | |
| SCHEMBL1549839 | 0.83 | NPC1 (0.63) | GAANPC1TP53LMNAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 227 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117187229-A | Preparation method and application of supermolecule gel ANAMMOX enhanced embedded microorganism with load response function | 浙江浙能技术研究院有限公司 | 2023-12-08 | — | — | CN | claimed |
| US-20090192220-A1 | TREATMENT FOR SOLID TUMORS | ORE PHARMACEUTICALS INC. (US) | 2009-07-30 | — | — | US | claimed |
| WO-2009067397-A2 | TREATMENT FOR SOLID TUMORS | ORE PHARMACEUTICALS INC. (US) | 2009-05-28 | — | — | WO | claimed |
| US-6635091-B2 | Oxidation color dye and coupler | L'OREAL S. A. (FR) | 2003-10-21 | — | — | US | claimed |
| US-20020178512-A1 | Oxidation dyeing composition for keratinous fibres comprising a n-(2-hydrobenzene)-carbamate or a n-(2-hydroxy-benzene)-urea and a pyrazolopyrimine, dyeing methods | L'OREAL SA (FR) | 2002-12-05 | — | — | US | claimed |
| US-20020032934-A1 | Composition for oxidation dyeing of keratin fibers, comprising at least one oxidation base chosen from 5-methylpyrazolo(1,5-a)pyrimidine-3,7-diamine and addition salts thereof; dyeing processes using them | L'OREAL S.A. (FR) | 2002-03-21 | — | — | US | claimed |
| EP-1175198-A1 | OXIDATION DYEING COMPOSITION FOR KERATINOUS FIBRES COMPRISING A N-(2-HYDROBENZENE)-CARBAMATE OR A N-(2-HYDROXY-BENZENE)-UREA AND A PYRAZOLOPYRIMINE, DYEING METHODS | L'OREAL (FR) | 2002-01-30 | — | — | EP | claimed |
| EP-1155680-A1 | Oxidation dyeing compositions for keratinous fibres comprising at least 5-methylpyrazolo(1,5-a)pyrimidine-3,7-diamine as oxidation base ; dyeing method of use therof | L'OREAL (FR) | 2001-11-21 | — | — | EP | claimed |
| US-20010034914-A1 | Compositions for the oxidation dyeing of keratinous fibers comprising at least one coupler, and dyeing methods | L'OREAL S.A. (FR) | 2001-11-01 | — | — | US | claimed |
| EP-1129689-A2 | Keratinous fiber dyeing composition comprising N-(2-hydroxybenzene)-carbamate or N-(2-hydroxybenzene)urea derivatives as coupling agents and process for dyeing | L'OREAL (FR) | 2001-09-05 | — | — | EP | claimed |
| WO-2001062220-A1 | OXIDATION DYEING COMPOSITION FOR KERATINOUS FIBRES COMPRISING A N-(2-HYDROBENZENE)-CARBAMATE OR A N-(2-HYDROXY-BENZENE)-UREA AND A PYRAZOLOPYRIMINE, DYEING METHODS | L'OREAL (FR) | 2001-08-30 | — | — | WO | claimed |
| EP-0345553-B1 | Photographic recording material | AGFA GEVAERT AG (DE) | 1995-09-13 | — | — | EP | claimed |
| EP-0329016-B1 | Colour-photographic recording material | AGFA GEVAERT AG (DE) | 1994-03-23 | — | — | EP | claimed |
| EP-0235878-A2 | Novel compounds | BEECHAM GROUP PLC (GB) | 1987-09-09 | — | — | EP | claimed |
| EP-0044729-B1 | COBALT (III) COMPLEX-CONTAINING IMAGE-FORMING COMPOSITIONS | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1984-09-26 | — | — | EP | claimed |
| EP-0022750-B1 | 1,3,4-THIADIAZOLYLOXY-PHENYL UREAS, THEIR PREPARATION AND HERBICIDES CONTAINING THEM | CIBA-GEIGY AG (CH) | 1983-05-18 | — | — | EP | claimed |
| EP-0044729-A1 | Cobalt (III) complex-containing image-forming compositions | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1982-01-27 | — | — | EP | claimed |
| US-4294912-A | INCLUDING A SECOND DESTABILIZER; COLOR FILMS | EASTMAN KODAK COMPANY (US) | 1981-10-13 | — | — | US | claimed |
| EP-0001556-B1 | CYCLOHEXENONE DERIVATIVES, METHOD OF THEIR PREPARATION, HERBICIDAL COMPOSITION CONTAINING THEM AND USE OF SAID CYCLOHEXENONE DERIVATIVES AND HERBICIDAL COMPOSITION, RESPECTIVELY | STAUFFER CHEMICAL COMPANY (US) | 1981-06-17 | — | — | EP | claimed |
| EP-0001556-A2 | Cyclohexenone derivatives, method of their preparation, herbicidal composition containing them and use of said cyclohexenone derivatives and herbicidal composition, respectively | STAUFFER CHEMICAL COMPANY (US) | 1979-05-02 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010034914-A1 | Compositions for the oxidation dyeing of keratinous fibers comprising at least one coupler, and dyeing methods | KRT18, FH, FGB | GAA 4640/4885NPC1 4448/4885TP53 2636/4885 |
| US-20020178512-A1 | Oxidation dyeing composition for keratinous fibres comprising a n-(2-hydrobenzene)-carbamate or a n-(2-hydroxy-benzene)-urea and a pyrazolopyrimine, dyeing methods | FH, KRT18, CYB5R3 | GAA 4734/4885NPC1 4742/4885TP53 1501/4885 |
| US-20090192220-A1 | TREATMENT FOR SOLID TUMORS | ACAT2, ACAT1, APRT | GAA 29/4885NPC1 410/4885TP53 70/4885 |
| US-20020032934-A1 | Composition for oxidation dyeing of keratin fibers, comprising at least one oxidation base chosen from 5-methylpyrazolo(1,5-a)pyrimidine-3,7-diamine and addition salts thereof; dyeing processes using them | KRT18, UNG, DPYD | GAA 4737/4885NPC1 4829/4885TP53 2111/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.